Tariff revenue declined month-over-month for the first time since President Donald Trump imposed import taxes in April, according to Treasury Department data released on Wednesday. The government collected $30.75 billion in customs duties in November, down from $31.35 billion in…
On Friday, Sen. Bernie Sanders (I-Vt.) praised a bipartisan House vote overturning Donald Trump's executive order that stripped collective bargaining rights from more than one million federal workers, urging the Senate to swiftly approve the measure. Sanders Hails House Reversal…
Slovak Prime Minister Robert Fico stated he will not support any European Union (EU) solution backing Ukraine’s military expenditures at the upcoming Brussels summit. During a phone call with European Council President Antonio Costa on Friday, Fico said he told…
On Friday, Tesla (NASDAQ:TSLA) CEO Elon Musk said on X that South Africa now has more anti-white laws than it had anti-Black laws during apartheid. Musk called this “deeply wrong” and advocated for eliminating all race-based legislation. The South African-born…
The U.S. has lifted sanctions on a Brazilian Supreme Court justice previously targeted by President Donald Trump's administration. This development underscores a rapid diplomatic reset with Brazil as trade tensions ease and relations with President Luiz Inacio Lula da Silva…
President Donald Trump's sweeping executive order aimed at curbing state-level artificial intelligence (AI) regulation is triggering fierce political backlash, legal questions, and sharply divided reactions across Washington, labor groups, and Silicon Valley. Trump Pushes Single National AI Framework Trump on…
The global conversation around digital assets is shifting from speculative market cycles to deeper questions about blockchain surveillance, compliance and the future of privacy. As regulators intensify their focus on how cryptocurrency transactions are monitored, the stakes are rising for…
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stock is trading lower on Friday, with a session volume of 42.39 million compared to the average volume of 3.51 million as per data from Benzinga Pro. • Tenaya Therapeutics stock is feeling bearish pressure. What’s pressuring…
The U.S. Food and Drug Administration (FDA) on Thursday approved Amgen Inc.’s (NASDAQ:AMGN) Uplinza (inebilizumab-cdon) for generalized myasthenia gravis (gMG). The approval covers adult patients who are anti-acetylcholine receptor (AChR) and anti-muscle-specific tyrosine kinase (MuSK) antibody positive. gMG is a…
Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and…